Key facts
- This page summarizes Patrick G. Enright's Form 4 filing for Vera Therapeutics, Inc. (VERA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Apr 2022, 07:22.
Patrick G. Enright - 10 Feb 2022 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- VERA
- Reported as of
- 10 Feb 2022
- Net transaction value
- +$4,999,995
- SEC form
- 4
- Accepted by SEC
- 05 Apr 2022, 07:22:45 UTC
- Prior SEC filing
- 20 Aug 2021
- Next SEC filing
- 26 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patrick G. Enright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick G. Enright filed Form 4 for Vera Therapeutics, Inc. (VERA) on 05 Apr 2022.
Change
- Previous filing in this sequence was filed on 20 Aug 2021.
- Current net transaction value: +$4,999,995.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VERA
transaction
Class A Common Stock
Purchase
- Transaction value
- $4,999,995
- Shares
- +333,333
- Change %
- +11%
- Price
- $15.00
- Shares after
- 3,429,927
- Date
- 10 Feb 2022
- Ownership
- See footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These shares are held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
SEC remarks
This Form 4 is being filed late due to an administrative error.